BOSTON SCIENTIFIC CORPORATION Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax
BOSTON SCIENTIFIC CORPORATION (BSX) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax of -$106.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-20.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax · last filed 2018-02-20
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2017 was -$106.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2016 was -$45.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2015 was -$67.00M, a 185.90% decline from fiscal 2014.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2014 was $78.00M, a 27.10% decline from fiscal 2013.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 12 month |
|---|---|
| 2017-12-31 | -$106.00M 10-K · filed 2018-02-20 |
| 2016-12-31 | -$45.00M 10-K · filed 2018-02-20 |
| 2015-12-31 | -$67.00M 10-K · filed 2018-02-20 |
| 2014-12-31 | $78.00M 10-K · filed 2017-02-23 |
| 2013-12-31 | $107.00M 10-K · filed 2016-02-24 |
| 2012-12-31 | $82.00M 10-K · filed 2015-02-25 |
| 2011-12-31 | $17.00M 10-K · filed 2014-02-26 |
| 2010-12-31 | -$28.00M 8-K · filed 2013-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |